Compare Kinder Morgan Inc (KMI) vs Moderna, Inc. (MRNA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Kinder Morgan Inc vs Moderna, Inc. — how do they compare? Kinder Morgan Inc trades at $32.47 (market cap $72.48B), while Moderna, Inc. trades at $59.72 (market cap $23.60B). The key difference: Kinder Morgan Inc is far larger — about 3.1× Moderna, Inc.'s market cap, and Kinder Morgan Inc pays a 3.61% dividend while Moderna, Inc. pays none. Which is the better fit depends on your goals.
| KMI | MRNA | |
|---|---|---|
Market Cap | $72.48B | $23.60B |
Sector | Energy | Health |
52-Week High | $34.31 | $81.80 |
52-Week Low | $25.84 | $22.36 |
Enterprise Value | $104.36B | $19.70B |
Dividend Yield | 3.61% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Kinder Morgan Inc
Kinder Morgan is one of the largest midstream energy firms in North America, with an interest in or an operator on about 83,000 miles in pipelines and over 140 storage terminals. The company is active in the transportation, storage, and processing of natural gas, crude oil, refined products, natural gas liquids, and carbon dioxide. The majority of Kinder Morgan's cash flows stem from fee-based contracts for handling, moving, and storing fossil fuel products.
Read more on KMI →About Moderna, Inc.
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →
